Senior insider sale
PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$1.20M
12K shares
What this filing means
GIRAUDO BRYAN plans to sell 12K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $1.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/7/2026ACC: 0001950047-26-004218
Director
Since Jun 2019
12K
Shares to sell
$1.20M
Approx. market value
12K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Compensation
Not Applicable
12/3/2019
2KCompensation
Not Applicable
5/16/2018
10KTotal acquired12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/3/2019 | Compensation Not Applicable | 2K | — |
5/16/2018 | Compensation Not Applicable | 10K | — |
| Total | 12K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
12K
Market value
$1.20M
5/7/2026
Total
Units
12K
Value
$1.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/7/2026 | 12K | $1.20M | NASDAQ | Planned |
| Total | 12K | $1.20M | ||